■非转移性但异常高风险的前列腺癌患者容易出现生化衰竭，甚至可能死亡。三联疗法,包括手术，放射治疗,和雄激素剥夺疗法，作为一线治疗，可以长期控制疾病。
■我们治疗了一名高危患者,非转移性前列腺癌,三联疗法。他在开始治疗后60个月无生化复发。
■三联疗法可能是高危人群的一种选择，非转移性前列腺癌.
UNASSIGNED: Patients with nonmetastatic but exceptionally high-risk prostate cancer are liable to have biochemical failure and may even die. Triple combination therapy, which consists of surgery, radiotherapy, and androgen-deprivation therapy, as first-line treatment, may control the disease for a long period.
UNASSIGNED: We treated a patient with super-high-risk, nonmetastatic prostate cancer, with triple combination therapy. He was biochemical relapse free at 60 months after the initiation of treatment.
UNASSIGNED: Triple combination therapy may be an option for super-high-risk, nonmetastatic prostate cancer.
PDF(Pubmed)